Please login to the form below

Not currently logged in
Email:
Password:

Pfizer resurrects its OTC bid for Viagra in the UK

Confirms MHRA review of new pharmacist-supplied status has begun

Pfizer

Nearly nine years after its last attempt to make its blockbuster erectile dysfunction treatment available without a prescription, Pfizer is having another go.

UK regulator the MHRA has began reviewing an application to allow Viagra (sildenafil) to be made available without a prescription if supplied by a pharmacist - a move that would grant it ‘P’, though not OTC (over-the-counter), status.

If approved, Pfizer’s plans would see it continue to market the medicine as a prescription-only treatment under the Viagra brand and then it would provide pharmacists with training on dispensing sildenafil at a 50mg dose.

Pfizer’s UK medical director Dr Berkeley Phillips said: “The availability of pharmacist-supplied, non-prescription sildenafil could offer men a new and additional way to access a legitimate, long established, and well-studied treatment for erectile dysfunction.

“This could have further benefits as the condition may be an early warning sign of a more serious underlying condition, such as heart disease4, which may otherwise go undetected.”

Pfizer has previously tried for European approval to make Viagra available without a prescription, but those plans were scuppered in 2008 after regulatory advisors voiced concerns about misuse of the drug.

Article by
Dominic Tyer

28th March 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics